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Organising Chairman's Message 
Welcome to the Land of the Hornbill ! 
On behalf of t he Organising Committee, I wou ld like to 
welcome all o f you to our 2019 Annual Scientific Meeting 
of College of Pathologists, Academy of Med icine 
Malaysia, which will be held on 27-28 June 2019 at 
Riverside Majestic Hotel, Kuching, Sarawak. 
This marks the first time the meeting is held in Cat City, Sarawak. 
The theme for th is year's annual scient ific meeting is "()P/l4'~ ud eJ~u u, 
..t~ ~" . It will highlight on the existing challenges and possible 
opportunities in our respected fields as well as updates on the advances and 
innovations in diagnostic pathology. 
This meet ing wi ll provide a platform for all of us to refresh our knowledge and to 
dii ect ly learn from the experts on their approaches to diagnost ic di lemmas. It is also an 
opportunity to meet up with old friends, make new networking with leading researchers 
and experts against the backdrop of Sarawak River. 
t would like to thank our invited speakers who have kindly agreed to participate in the 
meeting. On behalf of the organising committee, we wish all participants to have a 
fruit ful meet ing and we look forward to seeing you in Kuching. 
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27-28 June 2019 
President's Message 
On behalf of the College of Pathologists, Academy of 
Medicine Malaysia, I would like to welcome you to our 
Annual Scientific Meeting (ASM), to be held on 27 lh_28Ih 
June 2019 in Kuching, Sarawak. 
I am certa in that th is year's ASM will serve as an excel lent opportunity fo r all 
participants to upgrade our knowledge in different disciplines of pathology as well as 
addressing the cha llenges that we face in our laboratory medicine. I hope that the 2­
day-program planned wou ld enhance your professional development which will lead to 
improvement in the quality of laboratory medicine and patient care. 
I would like to express my gratitude to our experienced invited speakers who have 
kindly agreed to spend their precious time to share their expertise with us. Last but not 
least, to all participants, I hope you have a fruitful and enjoyable meeting in the land of 
the Hornbills. 
Emeritus Professor Dr Cheong Soon-Keng 
President 
College of Pathologists 
Academy of Medicine of Malaysia 
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REGIS'TRATION & OPENING HOURS 
Venue level 3 Foyer and Pre-Function Area 
Opening Hours 
27 June 2019 (Thursday) 7.00 am - 5.00 pm 
28 June 2019 (Friday) 7.00 am - 5.00 pm 
Participants, exhibitors and guests may register, make enquiries and pick up materia ls at the 
registration counter which is situated at Foyer and Pre-Function Area . 
IMPO RTANT VENUES 
Registration level 3 Foyer and Pre-Function Area (27-28 June 2019) 

Plenary Sessions Sarawak Chamber I and II 

Breakout Sessions Deer & lady Suites, Wind Suites I & II 

Lunch Symposia Sarawak Chamber I and II 

Tea breaks Level 3 Foyer, Corridor and Pre-Funct ion Area 

Secretariat Room Business Centre II 

Speaker Preparatory Room Business Centre II 

Poster Presentation Sara wak Chamber II I 

CERTIFICATES OF ATIENDANCE 

All registered and paid delegates w ill be issued the certificates of attendance. The cert ificates 





l unches w ill be served at Coca Thai Restaurant (3 rd floor) and Cafe Majestic (11 ! floor). 







Participan ts who are presenting posters are requ ire d to mount their posters in Sarawak 

Chamber III from 7.00 am - 12.00 pm on 27 June 2019 (Thursday). Please ensure that posters 

are mounted on the correct boards. Acrylic tapes are available from the registration counter. 

The posters should be taken down before 4.00 pm on 28 June2019 (Friday); any unattended 

posters will be discarded by the panel vendor after 4.00 pm. 

BEST POSTER AWARDS 

Three (3) best posters in each of the two categories (origina l article and case report) will be 

awarded certificates and cash prizes for their outstanding work. The winners will be announced 
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GROUP PHOTO - ORGANISING COMMlnEE 
Members I standing from left to rieht ) 

Tay Siow-Phing, Dr Siti Fazilah Situ, Norhadzline Harun, Dr Nor Anisa Md Radzi, Dr Noraini M ohamad, Dr James lee Jia-Haur, 

Dr Um Say-Min, Dr M ohd Hafiz Riza n, Dr Thien Jun-Jun, Dr Jasmine Kueh Wui-Thing, Dr Nur Aini Abu Bakar 

Members I sitting from left to right) 

Dr Khamisa h Mohd Gaus, Prof Dr Henry Rant ai Gudum, Prof Dr Mohammad Zu lkarnaen Ahmad Narihan, 

Dr Ja cqueline Wong Oy-l eng, Dr Madzlifah Ahadon, Prof Dr Oayangku Norlida Awang Ojep, Dr Mohammad Masrin Md Zahrin 

Other Members 
lau Kim-See, Dr Stephen Chew Jink-Yang, Dr Adam Mali k Ismail, Dr Norliza Ibrahim, Mohd Rozi Ramli, Mohamad Sukran Kana, Dunstan Goh Seng-Chee, 





Day 1 : 	21 June 10t9 ( Thursday I 
0745-0845 Registration 
0845-0900 Welcoming Address & Opening Ceremony 
Kprathap Memori;,I:lecture 
Opportunities and Challenges for Laboratory Professional In Patient Safety 
0'J00.094O Speaker: Doto' Dr Yosmin Ayab (Notionol Heart Inst/lIIte) 
ChOlrperson: Pro{ Dr Mohommad Zulkomoen Ahmad Norinan 
SClf(JIlot ("],(lmbl:l" J 
0940-1020 Group Photo Session & Tea Break 
Plenary 1 
Challenges In Oialnosis of Monoclonal Gammopathy1020-1100 
Speaker: AP Dr Pavo; Sthoneshwor (University Maloya Medical Centre) 
Choiroerson: ex Um Soy-Min Saru"rlk Chamher I -
Plenary 2 
1100-1140 Challenges in Rabies Diagnosis ; The Sarawak experience 
Speaker: Dr Chua Hock-Hin (Sarawak General Hospital) 
ChaifDerson: Dr Siti Fazilah 5itll Sa/"(j\Wlk Chomher ' 
lunch Symposium 
Roche Healthcare Consulting I by Roche Diagnostics J 
1140-1220 Speaker: Mr Moh Sam- Yew (Consulting Team Manager, Lab Workflow Solution_Roche APAC) 
Chairperson: Prof Dr Mohammad ZlIlkarnaen Ahmad Nanhan 
Sarull'ok CJrmnbcr I 
1220-1400 l unch Break 
Symposium 1A Sym posium 18 SympQ<;ium lC 
If itld Slli rt!!l I & /I .'Iilro ll"ut Chumrnr I 1).-.,. &: 1.".1.. Smrl!.' 
Anatomical Pathology Haematology Che mical Pathology 
Forensic Medicine Transfusion Medicine Microbiology/Immunology 
CP _Dr Adam Malik Ismail CP : Dr Khamlsah Mohd Gaus CP . Dr ThIen Jun·Jul1 
Approach to Soft Tissue Opportunities and Standa rdised Re porting of 
Tumours with Myxoid Challenges in Haemostatic Serum Protein 
1400-1440 Stroma Tests Electrophoresis 
Dr Noroini Mohd Ouso Prof Dr Wan laidah Abdullah AP Dr Pavai Sthaneshwar 
(Hosaital Kuala lumpurJ (Universlri 50l(ls MalaVilo) I [U MMC) 
pftfa ll$ in Diagnosis of Red Cell Membrane Updates In Biochem ica l 
Soft Tissue Tumours Disorde r: Challenges In lipid Testing 
1440-1520 Dr Noroini Mohd DU$o Diagnosis AP Dr Subashinl C 
(Hospital Kuala Lvmpvr) Prof Dr NarOloh Mond Yusoff Tnambiah 
(Unillersiti Sains Malavsla) (Unilltrsitl Putra Malaysia) 
Elusive Causes of Death: Approach In Ma naging Candido DUriS Infecbon: 
Pinning our Hopes on Thalassaemia from Emerging Fungal Disease 
1520-1600 
LaboratofY examination Transfusion Service AP Dr Tzar M ohd Nizam 
Dr Rozuin Rahiml Perspective Kho, rhir 
(UITM) Dr Nor Hafizoh Ahmad (UKMMC)
I (NotIonal Blood Cenlre) I 
1600-1630 Tea Break i 
20'" AGM of College of Pathologists, AMM I1100-1900 , I 
...1~30.2200.,j, -=­ ~, Faculty Dinner (by Invltatton) 
'fH- If! 8 
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Prof Dr Ric' 
, iCC"'", 








Or Heo ChOl 
Opportunities ~ 






1420-1500 I	Pllfall, In InO .. 
















.. nl. -, 
~ So/ution, Roche APAC) 
" 
, 
S... rllposium Ie 
D.·..'r ei / 
Chemical Pathology 
~1 crobiology/lmmunology 
CP Dr rh/en JUrl -/Url 
I Reporting of 
Serum Protein 
Elect rophoresis 
.!o f) Dr Pavoi Sthaneshwaf 
~C) 
, In I I 
Upid Testing 
AP Dr Subashim C 
- '1omblah 
, aurl, 
Emerging Fungal Disease 
A:- Dr Tzar Mohd Nizam 








Challenges In Diagnosis of Pigmented Lesions 
Speaker: Prof Dr Richord Seolyer (Melanoma Institute Australia) ­ invited RCPA speaker, 
Chairperson: Dr Jacqueline Wong Oy-Leng Sa/"awol< Chambttr I 
Plenary 4 
0840-0920 Blood Transfusion Service : Achievements and Challenges 
Speaker: Dr Noryati Abu Amin (Not/onoIBlood Centre) 
Chairperson : Dr Jacqueline Wong Oy-Leng Sarawak ChamMf I 
0920·0940 Tea Break 
Symposium 2A Symposium 28 Symposium 2C 
Wi"d Suites J & If S('l1"Ulli!.1k Clu/lflher I D.'a & Luth· SIIII(',\ 
Anatomical Pathology Haematology Chemical Pathology 
Forensic Medicine Transfusion Medicine 
I 
Microbiology/Immunology 
CP : Dr Noroini Mohomod CP, Dr Masrm MrJ lohrm Cp.:!2r Lim Sov"Min 
Approach to Inflammatory Journey to Good Tumour M arkers: 
0940-1020 
Skin Disorder M anufacturing Pra«ice IApplications and Abuses 
Dr Ikmal Hisyam Bakrin Dr Noryatl Abu Amin Dr Leslie Charles La! 
(Universiti Putra Molaysia) , /Natlonal Blood Centrel (Gleneagles Hmpicol) 
Melanoma vs. Naevus: Genomic. Profiting In Acute Designing and Evaluating 
Strategies for Difficult l eukaemias Auto-Verification Rules for 
1020·1100 Decision Dr lubardah lakaria Chemical Pathology Tests 
Prof Dr Richard Scolyer (Institute Medical Research) Dr Mohd Jamson; Mar Salleh 
(Me/anomo Institute Australia) I (Hospital Pu/ou Pinong) 
Evolving Concepts and Hot Immunophenotyping in Epidemiology of 
Topics in Melanoma Acute l eukaemlas: Plasmodium knowles;; 
1100·1140 
Professor Dr Richard Swlyer Challenles and Issues Need for a New Rapid 
(Melonoma Institute Ausfralia) Dr Lee Shlr-Ylng Diagnostic Tool? 
(National University H05Plto~ Prof Dr Bolbir Singh 
Singapore} (Unlvelsrti Malays/a Sorawo/c)
-­
Forensic Entomology in Multiple Myeloma Diagnosis Introduction to Transplant 
1140-1220 
Malaysia: Opportunities for Challenges and Issues Immunology 
Service EKpansion Dr Lau Lee·Gong Dr Masifa Arip 
Dr Heo Chong-Chin (UrrM) (Borneo Medicol Centre Ktu;f)[ng) (Institute Medical Research) 
luneh Symposium 
Opportunities and Ckalienges in Hlgk Sensitive Troponin I by Beckman Coulter J 
1220-1300 Speaker: AP Dr Robert Charles William Hawkins (Ton Tock Seng Hospital, Singapore) 
Chairperson: Prof Dr Henry Rantoi Gudum 
Saran'ok Cimm/x!" ! 
1300-1420 Lunch Break 
Symposiu m 3A Symposium 3B 
Saruwak Chamber I l>..v & LOth-Suire!> 
Anatomical Pathology & Haematology Chemica! Pathology & Microbiology 
CP : Dr Madz'-if~h Ahodon CP : Dr Nor AflIsa Md Rodzi 
Pitfalls In Inflammatory Dermatopathology Updates in laboratory Testing for Diabetes
1420-1500 
Dr Lee Bong-Rom (Pontoi Premier Hospital) Dr Leslie Charles Lal (Gleneagles Hospital) 
Myeloproliferative Neoplasm Diagnosis: Challenges in Ensuring Quality 
1500· 1540 
Challenges and Issues Performance in Microbiological laboratory 
Dr Lee Shir · Ying in tke Conte)Ct of ISO 15189 
(Notiarlol University Hospital, Singapore) Mr Alell Froncis (Slonrtards Malaysia) . ­
1540-1100 Prize Giving & Closing Ceremony 
v~ 
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Mr. Alex Francis 
Srortdords MolaysJo, Kuala Lumpur, Mo/o-"ia 
Mr. i is retired Senior Microbiologist formerly from Hospital Raja Permaisuri Bainun, Ipoh 
Perak. He has 34 years of labora tory experience in Medical Microbiology. He completed his degree In 
microbiology from University of Malaya in 1983. In 1990 he did his diploma in Med M1cro from 5eomeo 
Tropmed. In 2004, he completed his masters in Medical Microbiology from Universiti Sains Malaysia. He 
was sent for a fellowship in medical mycology to Australia in 2006. He is known for his development of 
Francis media which is used for the diagnosis of melioidosis which won him the 2006 Civil service 
Innovation award . Mr. Alex has been involved with Quality Management System specifically ISO 15189 for 
the past 16 years. He was trained by NATA (Nat ional Association of Testing Authority, Australia) and 
Department of Standard Malaysia . Currently, he is a techn ical assessor in Medical Microbiology and lead 
assessor for 15015189 for Department of Standards Malaysia. He has recently been appointed as Internal 





Professor Dr. Balbir Singh 
MaJario Research Cenrre, Un/veniti Malaysia Sarawak (UN/MAS), Koto Samorohan, 
Sorawok, MoJoysio 
Professor Dr. i Singh is the founding director of the Malaria Research Centre, Universiti Malaysia 
Sarawak (UNIMAS). He obtained his BSc, MSc and PhD degrees from the University of Liverpool (1976· 
1984). He worked as a Postdoc and as a Belt Medical Fellow on falciparum malaria at the Liverpool School 
of Tropical Medicine for 7 years. He joined Universiti Sains Malaysia in 1992 and moved to UNIMAS seven 
years later . His research team has made several key discoveries ind icating that knowlesi malaria is a 
significant, life-threatening zoonotic disease In Southeast Asia. His research has been funded by local and 
international funding agencies, including the Wellcome Trust, UK. He has published in leading journals, 
including The l ancet and his work has been cited 4,0001 times with an h-index of 32. He is a reCipient of 
the Merdeka Award (2017), is a Fellow of the Academy of Sciences Malaysia, was one of the recipients of 
the Top Research Scientists Malaysia 2012 Awa rd . and was an advisor to the World Health Organisat ion 
on two occasions (2012 and 2017). 
Dr. Chua Hock-Hi" 
Sorowok General Hospital (SGH), Kuchiflg, SO/crwok, Molaysio 
Hook-Hio is the Sarawak State Infectious Disease Physician based at the Infectious Disease Unit 
of the Sarawak General Hospital. Kuching. He graduated with a MD from the National University of 
Malaysia in 1998 and obtained his MRCP (UK) in 2003. He underwent postgraduate training in infectious 
disease in 2009. He had served in several Ministry of Health hospitals prior to his present appointment. 
He has presented in many scientific conferences and has several journal publications. He has contributed 
to several chapters of the "Sarawak Handbook of Medical Emergencies", which is a widely all over 
Malaysia. He has been an adjunct lecturer at the Faculty of Medicine and Health Sciences, Universltl 
Malaysta Sarawak.. He is activelv involved in clirncal tnals and currently the Principal Investlptor In 
OAlolnS clinical tnals in the areas of infectious diseases. 
1 
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Dr , Heo ChongMChin 
UtllverslrJ Teknologi MARA (UfTM), Sungal Buloh, 5elangor, Malaysia 
li ' was born In Kuantan, Pahang. He obta ined his Bachelor in BiomedIcal Sciences 
(Hans.) (2006) and Master in Medical Science (Parasitology) (2009) from the National University of 
Malaysia . He then earned hIs PhD from the Department of Entomology, Texas A&M UnIversity in 2016. He 
is current ly a Senior Lecturer at the Faculty of Medicine, Universiti Teknologl MARA, Malaysia. Prior to 
that, he was a research officer at the Institute for Medical Research, Kuala lumpur. His research interests 
are carriol) decomposition ecology, biodiversity of necrophagous and coprophagous dipteran species, and 
forensic entomology/acarology. As of 2018, he has published 46 peer-reviewed Journal artIcles, one book 
and one book chapter. He delivered more than 70 platforms and poster presentatIons at local and 
international conferences. He received the Nadchatram Medal from the Malaysian Society of ParasItology 
and Tropical Medicine (MSPTM) In 2018, the John Henry Comstock Gradu ate Student Award from the 
Entomological Society of America at Denver, Colorado (2017), Perdana Scholar Award from the Malaysi an 
Embassy at Washington DC (2016); the Vice President Award for Research Excellent from Texas A& M 
University (2015); and a scholarship from Medical, Urban, and VeterInary Entomology section, 
Entomological Society of America during the 2015 ESA Conference at Minneapolis. Additionally, Chong 
Chin is a Board-CertifIed EntomologIst (BCE) since 2016. Currently, he is the Honorary Secretary for the 
Malaysian Society of Parasitology and Tropical Medicine, member of the North American Forensic 
Entomology Association (NAFEA) and European Association for Forensic Entomology (EAFE). 
Dr. Ikmal Hisyam Bakrin 
Un /versit/ Pu rra Malaysia (UPM), Serdang, SeJangar, MalaySia 
Dr. Ikmal Hisyam Bakrin is a Histopathologist: and Medical Lecturer at the Department of Pathology, 
Faculty of Med icine and Health Sciences, Universiti Putra MalaySia. He graduated from Universiti 
Kebangsaan Malaysia with a MD in 200S and subsequently obtained his Master of Pathology also from 
Unlversiti Salns MalaysIa in 2014. He was a Visiting Fellow in Dermatopathology at St. John's Institute of 
Dermatology, Department of Dermatopathology, Guy's and St. Thomas' NHS Foundation Trust, London, 
UK from July 2018 til l January 2019. He has several conference presentations and journa l publications. His 
current research includes potential prognostic immunohistochemistry mark ers in prostate cancer, gene 
expression profiling and mutation screening of RAD51, XRCC3 and XRCC2 genes in prostate cancer. 
Dr. lee BangMRom 
Un/versirl Putra Malaysia (UPM), Serdang, Selangar, M alaysia 
B,ngCR"m is currently a lecturer and Histopath:::;!ogist at the Department of Pathology, Faculty of 
Medicine and Health Sciences, Universiti Putra Malaysia. He obtained his MBBS from University of Malaya 
in 1999 and Master of Pathology from Universit i Keba ngsaan Malaysia in 2007. He also obtained a 
Diploma in Dermatology from t he National University of Singapore in 2011. He had served In various 
Ministry of Health hospitals before jOining UPM. He has published several j ournal articles and his research 
interest includes breast cancer and endometr ial cancer research. 
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Dr. lau lee-Gong 
Borneo Medlcol Centre (BMC). Kuching. Sarowok, Molaysia 
Dr. lau lee-Gong is currently the Consultant Haematoiogist at the Borneo Medical Centre, Kuching, 
Sarawak. He graduated with MBBS from the UnIversity of Malaya in 1992 and obtained his MRCP (UK) 
membership in 1997. He was a clinical specialist In the Department of Medicine at the Sarawak General 
Hospital, Kuching, before he left for further training In haematology at the Nationa l University Hospital in 
Singapore in 1999. He completed his trainIng in 2003 and became an Associate Consultant at the 
Department of Haematology-Oncology at the National University Hospita l, Singapore. He was also then 
the attending staff haematologist at the John's Hopklns-NUH Medical Centre from 2003-2005. Upon 
returning to Kuching in 2005, he f irst worked in Normah Medical Specialist Centre as a Consultant 
Haematologist before taking up his current appointment at Borneo Medical Centre in 2015. He was 
formerly an adjunct lecturer at the National University of Singapore and now an adjunct lecturer at the 
Faculty of Medicine and Health Sciences, Universiti MalaysIa Sarawak. His special interests are in t he area 
of haematological malignancies and flow cytometry. 
Dr. lee Shir-Ying 
Notiorlo/ University Hospitol (NUHJ. Singapore 
Sh;,·Y'o. currently holds several positions; 1) Senior Consultant Haematologist, Department of 
Laboratory Medicine. National University Hospital. Singapore. 2) Senior Consultant, Department of 
Haematology-Oncolgoy, National Un iversity cancer Institute Singapore and 3) Assistant Professor, 
Department of Medicine. Yong Loo lin School of Medicine (YlLSOM), National University of Si ngapore. 
She obtained her MBBS from National University of SIngapore in 2002 and MRCP (UK) in 2006. She was 
conferred FRCPatn (UK) in 201 2. She has published several journa l articles and many abstracts. 
Dr. Leslie Charles Lai Chin-Loy 
G/eneog/es Hospitol. Kuola lumpur. Malaysia 
lai was l ecturer and Honorary Senior Registrar in the Unit of Metabolic Medicine at St Mary's 
Hospital Medical School, Imperial College School of Medicine in l ondon from January 1986 till September 
1990. He then moved up to Newcastle upon Tyne as Senior Lecturer and Consultant in Clinical 
Biochemistry and Metabolic Medicine at the Uni ve rsity of Newcastle upon Tyne, a pOSition he held from 
October 1990 till December 1996. He returned to Malaysia at the end of 1996 to t ake up the posit ion of 
Professor of Cli nical Biochemistry and Metabolic Medicine, and Deputy Dean of Academic Affairs at 
Universit! Putra Malaysia. In August 2001, he moved to the International Medical University in Kuala 
lumpur to take up the newly established post of Dean of the Postgraduate Medica! School. a position he 
held till February 2004. Dr leslie Lai current ly practices at Gleneagles Hospital in Kua la lumpur as a 
Consultant in MetaboliC Med icine and is the Laboratory Director of Pan tal Premier Pathology, Gleneagles 
o ·anch. He was President of the Asia-Pacific f ederation for Clinical Biochemistry and laboratory Medicine 
. -om 2010 till 2016, and is currently Chair of the International Federation for Clinical Chemistry Education 
d Management DiVIsion Executive Committee. Dr . leslie Lai Is the Associate Edrtor of the Malavslan 
.. rnal of Pathology and was the Associate Editor of Clinical Biochemistry rrom 2008 t i1l2018. He Is also a 
mber of the Editorial Baard of 6 other scientific· He IS the Chair of the M ACB ChronIc 
ase Task Foree 
I 
Mr Milh Sam-Yew 
Roch. Dlagnost/a Maloyslo, Kuolo lumpllr, Maloyslo 
Mr. Mah Sam-Yew Joined Roche Diagnostics Asia Pacific Regional team in June 2008 and currently holding 
the position of Consulting Team Manager, leading a t eam of lean Six Sigma Black Belt & Green Belt 
Practitioners responsible for supporting 16 countries in Asia Pacific in their laboratory Integrat ion 
projects with key accounts through laboratory workflow assessment, consultancy and customizing 
solutions that fit the laboratory's needs and goals. Prior to joining the Asia Pacific Regional team, Sam 
joined Roche Diagnostics Malaysia in June 2003. In the five years With the organ ization, he held multiple 
posit ions with increasing responsibility for the marketing, product and project management of lab IT and 
Workflow Solutions including installation, training and providing technical support. 
• 
Dr. Masita Arip 
Instilu te l or M edical Research (IMR), Kuala Lumpur, Moloysia 
Dr. I obtained her Medical Degree (MO) from National University of Malaysia (UKM) in 1999, 
and completed her Master of Pathology (Microbiology & Immunology) from UKM In 2008. She currently 
holds the posit ion as Head of Allergy & Immunology Research Centre (AIRC) in Institute for Medical 
Research (I MR), Kuala lumpur. Dr. Maslta Involved In more than 25 research projects focUSing on allergy, 
autoimmune, transplantation immunology and tropical diseases. She has published more than 25 original 
articles and proceedings in different type of journals. She had more than 70 oral and posters research 
presentations in national and international meetings. Dr Masita is the fi rst Head of Autoimmune Unit 
where she introducing more than 15 specialized diagnostic tests for autoimmune diseases. She provide 
consul tations on various specialized diagnostic service~ available in each unit under AIRC ie. Autoimmune 
Unit; Allergy Unit; Primary Immunodeficiency Unit and Transplantation Immunology Unit . She also 
responsible in setting up MalaySian Stem Cell Registry (MSCR) in year 2000 which is a database for 
healthy Malaysian volunteers who can donate blood stem cells to patients with blood disorders. In terms 
of Transplantation Immunology areas, she actively involved in National Stem Cells Coordinating Centre, 
National Coordinating Centre for Kidney Transplant, National Technical Committee for Transplantation 
and National Committee in Guidelines for Stem Cell Therapy. 
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Or. Mohd Jamsanl Mat Salleh 
Penang Hospital, Georpe Town, Penong, Moloys io 
Jamsani Mat Salleh Is a Chemical Pathologist at the Penang Hospital, George Town, Penang. He 
is currently Head of the Chemical Pathology Unit as well as Head of Chemical Pathology Discipline, 
Penang. He graduated with a MO from Universit i Sains Malaysia in 2003 and then obtained Master of 
Pathology (Chemical Pathology) also from USM In 2011. He is a member of several national professional 
committees and has been an invited speaker at national and International levels. 
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Dr. Nor Haflzah Ahmad 
National Blood C~ntre (PDN). Kuala Lumpur, M alaysia 
Dr. Nor Hafizah Ahmad is a Transfusion Medicine Specialist who is currently the Head of Clinical 
Transfusion Division in National Blood Centre, Kuala lumpur. She graduated from Universitl Sains 
Malaysia (USM) in 2004 and completed her specialist training in M .Med Transfusion Medicine in year 
2013 from Advanced Medical Dental Institute, USM. She is an active member of Malaysian Blood Society 
of Transfusion and her special interest is in the field of Immunohematology and Clinical Transfusion . She 
had also been invited as speaker in various conferences in local and national level. In the year of 2018 she 
had the opport unity to undergone a short attachment in International Blood Group Reference laboratory 
under NHS Blood and Transplant, Bristo l, United Kingdom . 
Professor Dr. Narazah Mohd YusoH 
Advanced M edical and Penta/Institute (AMDI), Unlversiti Sains M alaysia (USM), 
Bertam, Penang, Malaysia 
"N'''''h Mohd Yusoff is a Senior Consultant Haematopathologist and Medical lecturer at 
Advanced Medical and Dental Institute (AMDI), Universitl Sains Malaysja (USM) Bertam, Penang, 
~""alays i a. She graduated with MBBS from University of Malaya In 1986. She obtained Diploma in Clinjcal 
Pathology from the University of l ondon, UK in 1991and M. Med Science (Haematology) also from 
University of london, UK in 1994. She subsequently obtained her PhD from Kobe University Graduate 
School of Medicine, Kobe, Japan in 2003. Prior to this, she had held various pOSitions including 1) 
Consultant Haematopathologist and Medical lecturer in School of Medical Science, USM, Kelantan (1994­
2(03), 2) Head of Haematology Department, School of Medical Science, USM, Keiantan (1997-2000), 3) 
Research Fellow in Kobe Graduate School of Medicine, Kobe, Japan (1999-2003), 4) Director Human 
Genome Center, School of Medical Science, USM, Keiantan (2000-2003) and 5) Deputy Director Clinical 
Services, AMDt 2005-2011. Her research Interest s are in the areas of Oncogenic fusion genes, Molecular 
haematology, Clinical transfusion and Regenerative med icine. She has published more than 100 articles in 
local and international journals. 
Or. Noraini Mohd Ousa 
Hospital Kuala Lumpur (HKL), Kuala Lumpur. Malaysia 
I 
Or. Noralni Mohd Dusa is a consultant pathologist at the Department of Pathology, Hospital Kuala 
lumpur. She obtained her MD from Universiti Kebangsaan Malaysia (UKM) in 1992 and Master of 
Pathology also from UKM in 2001. She underwent further training in Osteoart icular Pathology at the 
University of Manchester, UK and in Bone and Soft Tissue Pathology at the Royal Orthopaedic Hospital, 
Brmingham, UK in 2007. She has been an invited speaker in the field of Bone and Soft TIssue Pathology to 
Ministry of Health Hospitals, local Universities, Malaysian Orthopedic Association, Asian Pacific 
-.1usculoskeletal SOCiety, International Anatomic Pathology - MalaySian Division and College of PathologV, 
~demv of Medicine Malaysia. She has published several journal articles and her research interests are 
~ the area of soft tissue t umours. 
Dr_Noryatl Abu Amin 
NGtiotlOl Blood Cenm (PDN), Kuala Lumpur, Moloysio,
t" .,.. _ , 
Dr. NoryaU Abu Amin is currently serving as the Director, Pusat Darah Negara (PDN), Kuala lumpur and 
the Head of Service for Transfusion Medicine, Ministry of Health of Malaysia. She received her 
undergraduate training in RCSI, Dublin, Ireland from 1987 to 1993 and completed her post graduate 
training as a Haematopathologist in Hospital University Salns Malaysia, Kubang Kenan in 2000. She has 
since worked in the fie ld of Transfusion Medicine and Haematology including over eleven years of 
experience as a Medical Officer in the Blood Transfusion Safety team in World Health Organiza tion, 
Geneva. Dr. Noryati Abu Amin has been involved In the development of policies, standards, guidelines, 
advocacy and training materials for blood transfusion safety and in the provision of technical support in 
several count ries for national blood system st rengtheni ng while in WHO. Her main Interest Is In ensuring 
equitable and t imely access to affordable, safe and effective blood products while ensuring the quality of 
care for pat ients, blood donors and health-care workers throughout the transfusion chain. Other key 
areas of interest include patient safety; health in emergency and disaster situation; and impact of 
globalization on plasma-derived medicinal products and other therapeutic substance of human origin. 
Associate Professor Dr. Pavai Sthaneshwar 
UniveNiry a/ Maloya (UM), Kuafo lumpur, Malaysia 
Associate Professor Dr. Paval Sthaneshwar is an Associate Professor at the Department of Pathology, 
Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. He obtained a B.Sc. (Chemistry) from 
Madras University, India in 1982, graduated with a MBSS (Madras Universi ty) in 1988 and subsequently 
obtained MD (Dr MGR Medical University Madras, India) in 1993. He is a member/ affiliate of several 
professional associations nationally and Internat ionally. He has been the Academic person in-<:harge of 
Chemical Pathology, DIvision of Laboratory Medicine, Department of Pathology, Faculty of Medicine (1 
May 2014 to 31 May 2015). He is also the MPath (Part II ) Coordinator He has published several journal 
art icles. 
Dr. Razu ln Rahimi 
Unlvers lrl Teknalogl MARA (UiTM), 5ungoi Bulah, 5elongor, M alaysia 
I Rahimi is a Senior Lecturer & Consultant Forensic Pathologist at the Faculty of Medicine, 
Universiti Teknologi MARA (UiTM), Sunga; Bulah, Selangor, Malaysia. She graduated with MO degree from 
Universitas Sumatera Utara, Medan, Indonesia in 2003 and obtained her Masters of Pathology (Forensic) 
form University of Malaya in 2010. She is also currently the Head of DISCipline, Forensic Medicine UiTM 
and t he Forensic Clinical Coordinator for PPPUiTM. She has published many journal articles and has 
completed several research projects. Her maIO research interests are in road traffic accidents and 
paediatric pathology. 
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Professor Dr. Richard $colyer 
~fonomo lnstItum AUltraHo. AustrallD 
Dr. Richard Scolyer currently holds severa l positions : 1) Co-Medical Director, Melanoma 
nstitute Australia, 2) Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince 
1I1fred Hospital, 3) Clinical Professor, The University of Sydney Central Clinical School, 4} Vice Chair, 
\/Ielanoma Expert Panel, American Joint Committee on Cancer Staging System, 8'h.• and 5) Edition Editor, 
Norld Health Organisation Classification of Skin Tumours, 4th Edition . He Is acknowledged internationally 
as an expert/key-opinion leader in melanoma/translational research who focuses on melanoma clinical! 
t:athologlcal diagnosis and treat ment. biology of melanoma pathogenesis and response vs. resistance to 
"lOVel drug therapies. He is staff specialist at a major teaching hospital & provides pathology service to 
Vlelanoma Institute Australia (MIA) (world's largest melanoma treatment centre) & a clinical consultation 
service for pathological diagnosis of difficult pigmented lesions (>2000 cases p.a. from throughout world). 
Professor Richard Scolyer is widely regarded as the point of reference for diagnosis of difficult pigmented 
esions in Australasian region & beyond. He effectively integrates his clinical practice w ith leading award 
"nning t ranslational melanoma research laboratory. According to Thomson Reuters lSI Web of 
(flOwledge, his highest ever published scient ist in world in melanoma pathology and highest H index In 
-f<! s field. In Feb 2019, he was ranked world's 10th leading melanoma expert in any field/discipline & 
_orld's leading melanoma pathologist (http://expenscape.com/ex/melanoma). His record includes co­
Olllthoring more than 500 publications including in prestigious journals such as New England Journal of 
edicine, lancet, Nature, Celt. Nature Genetics, Cancer Cell, lancet Oncology, Journal of Clinical 
Oncology, Journal of the National Cancer Institute and Cancer Discovery. He has presented on more than 
300 occasions at conferences throughout the world. He received a NSW Premier's Award for Outstanding 
Cancer Research in 2009, 2012. 2013. 2014, 2016, 2017 and 2018, Thomson Reuters 2015 Citation Aw ard 
"" the Clinical Medicine category and the 2018 William o . Russell/joanne Vandenberge Hill Award for 
~fetime Achievement in Anatomical Pat hology, MO Anderson Cancer Center and the Research Australia's 
2018 GSK Award for Research Excellence. His publications have received most highly cited awards on S 
:;eUler occasions. He is editor of the 4th Edition of the World Health Organisation Classification of Tumours 
5o'·n Tumours volume (released in 2018). Vice Chair of the Melanoma Expert Panel of the American Joint 
.:ommittee on Cancer (AJCC) for the 8th edition of AJCC Cancer Staging System, co-leads the Australian 
'elanoma Genome Project (part of the International Cancer Genome Consortium) (Nature 2108). was 
:~ pathologist for the NIH funded The Cancer Genome Atlas (TCGA) Melanoma Project (Cell, 2015), 
-hairs the Melanoma Expert Panel for the Internat ional Collaboration on Cancer Reporting. and lead 
~[hologist/member of the overseeing Management Committee, Multidisciplinary Working Party and 
luthor for the Australian Melanoma Clinical Practice Guidel ines and was lead author of the College of 
~.erican Pathologists Melanoma Reporti ng protocol. 
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Associate Professor Dr. Robert Charles William Hawkins 
Tart ToeA: ~ HoJplktl, Singapore 
,;:;O;"'''';;(;fe'50' Or. Robert Hawkins is a Senior Consultant Chemical Pathologist at the Tan Tock Seng 
Hospital. Singapore. He is also an Adjunct As!>OCiate Professor at lee Kong Chian, School of Medicine, 
Nanyang Technological University, Singapore. He graduated with a MBChB from Auckland University, New 
Zealand in 1986 and obtained his FRCPA (Chem Path) in 1992. He was 
University in 2011 and FFSc (RCPA) in 2012. He had been Consultant Chemical Pathologist 
Auckland Health, New Zealand (1993-1996) and Consultant Chemical Pathologist at Gnbbles Pathology, 
Malaysia (1997). He has been involved in both undergraduate and postgradua te 
member of many professional committees and societ ies. He has won several prizes including the Silver 
medal (Best Clinical Research Poster) at 2013 Singapore Health and Biomedical Congress for 'Prevalence 
of dilut iona! hyponatraemia in Inpatients and outpatients in Singapore' and Gold medal (Best Allied 
Health Research Post er) at 2014 Singapore Health and Biomedical Congress for 'Prevalence of transferrin 
variants in Singapore'. He has published more than 60 scient ific articles, reviews and numerous abstracts. 
Associate Professor Or. Subas hini C. Thambiah 
Unillersit i Putro Moloysio (UPM), 5eniong, 5elongoT, Motoyslo 
Associate Professor Dr. Subashinl C. Thambiah is an Associate Professor and Consultant Chemical 
Pathologist at the Department of Pathology, Faculty of M ed icine and Health Sciences, UniverSity Putta 
Malaysia (UPMJ, where she has served since 2004. Prior to this appointment, she was a medical officer at 
the Ministry of Healt h Malaysia for S yea rs. She obtained her MBSS from the University of Western 
Australia in 1999 and Master of Pat hology (Chemical Pathology) from Universiti Kebangsaan Malaysia in 
2009. In 2011, she completed her fellowship in Metabolic Medicine at Guys' & St . Thomas' Hospital, 
london, UK under the supervision of Prof. Dr. R. Swaminathan, Prof. Dr. Anthony Wierzbicki, Prof. Dr. 
Martin Crook and Dr. Geeta Hampson. She is registered with the National Specialist Register under 
Chemical Pathology (Metabolic Medicine). She is actively involved in academic teaching, scientific 
research, laboratory and clinical services. Her thrust areas of Interest Include lipid disorders and 
metabolic bone disorders. She is a member of the Malaysian Association of Clinical Biochemists and is 
currently the Secretary of the College of Pathologists, Academy of Medicine of Ma laySia. Dr. Subashini is 
also an active member of the Malaysian Osteoporosis Soci ety, MalaYSian Society of Atherosclerosis and 
also a member of the Asian-Pacific Society of Atherosclerosis and Vascular Disease. She is apPOinted by 
Standards MalaySia as a qualified assessor for SAMM Accreditation Process and Assessment for MS ISO 
I S189. She is currently offering clinical service at Hospital Serdang and Hospital Pengajar UPM and is a 
visiting consultant at Cllnipath (M) Sdn. Bhd. and Hospital Pusrawl Sdn. 8hd. 
Associate Professor Dr. Tzar Mohd Nizam Khaithir 
Uni'INSlti I(~bongsaan Malaysia (UKM), Ch~ros, KlHliG tumpur, Malaysia 
.;:;0;"", 'roIre,w Dr. Tzar Mohd Nizam Bin Khaithir is an Associate Professor at the Department of 
Medical M icrobiology and Immuno&ogy. He obtained his medical dell'ee (l RCPSI, MBSCh, BAO (IRE» from 
the Royal Coliele Sorseon, Ireland in 1999 and subsequently orPath (Med. Mlcrob) from UKM in 2007. He 
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Professor Dr. Wan Zaldah Abdullah 
Unlven lt/ Salns Malays/Q (USM), KubGnQ Kerian, Kelantan 
~ 
Professor Dr. Wan Za idah is a lectu rer/haematologist since 2001 at the Haematology Department and 
- rtlnsfusion Medicine Unit, School of Medical Sciences Universiti Sains Malaysia (USM) and Hospital USM, 
I(ubang Kerian, Kelantan. She has been actively involved in haemostasis and thrombosis including 
teachings and providing diagnost ic services in this area. In addition to her tlinical laboratory services and 
academic duties, she has been a researcher dedicated to furthering the understanding of haemostasis 
particularly in laboratory diagnosis and drug monitoring t hat can give impact to the patient care. She is 
currently Head of Coagulat ion laboratory section, laboratory Director for ISO 15189 Haematology and 
Transfusion Medicine laboratories in the same institution, and Committee Member of College of 
Pathologists, Academy of Medicine Malaysia. 
Dato' Dr Yasmin Ayob 
National Blood Centre (PDN).& Nat ional Heart Institute (IJN), Kuala Lumpur, Malaysia 
Dato' Dr. Yasmin Ayob is currently a visiting Pathologist at the National Blood Centre and National Heart 
nstitute and an honorary lecturer at the Advance Medical & Dental Institute, University Science Malaysia 
AMDl/USMJ. She was the first Director for the National Blood Center in Kuala lumpur. She Is President of 
::he Malaysian Blood Transfusion Society which she founded and formerly the Vice President of the 
Haemophilia Society of Malaysia which she is a founding member. In the international scene she is on the 
Expert Panel of World Health Organization (WHO) on Transfusion Medicine and Blood Safety, served on 
the Board of the International Society Blood Transfusion and the Editorial Board of Transfusion Medicine, 
:he official journal of the British Blood Transfusion Society. At present she is on the International AdviSOry 
Board for the Asian Journal of Transfusion . 
Dr. Zubaidah Zakarla 
Institute for Medical Research (IMR), Kuala Lumpur, Malaysia 
Dr. Zubaidah Zakaria is currently the Head of Cancer Research Cent re in inst itute for Med ica l Research, 
Kuala lumpur. She obtained her first degree in Medicine from University Malaya in 1984 and 
subsequently her postgraduate qualification in Pathology from University of london in 1994 . She was 
then appointed as the Head of Haematology Institute for Medical Research Kuala Lu mpur in 1995 . She 
.hen went on to pursue her subspeclality training in advanced molecular cytogenetics techniques in the 
Academic Department of Haematology and Cytogenetics, Royal Marsden NHS t rust and the Inst itute of 
(ancer Research UK in 2000. She was appointed as Head of Cancer Research Centre Institute for Medical 
Research in 2007. Her current research Interest is in the field of molecular cytogenet ics in leukaemias, 
cancer genetiCS, leukaemia and stem cell research. She had received research grants from IRPA/MOSll in 
the field of molecular molecular cytogenetics. array based technologies in haematological and solid 
cancers and recently awarded stem cell research grant from NIH/MOH. She provides services in the 
"1terpretation and analySiS of bone marrow cytogenetics, molecular studies in leukaemlas, array CGH and 
next gene sequencing. The Inst itute has the capabili ty in providing the necessary equipments and 
facilities for the relat ed experiments in &enomfC and animal studies. She had many related In 
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LECTURE SYNOPSES 
K Prathap Memorial Lecture 
Opportunities and Challenges for laboratory Professional In Patient Safety 
(Dato' Dr. Yasmln Ayob ) 
Pathology has been the engine of healthcare system in understanding diseases and in the last 
few decades In monitoring therapy. However, the approach and technique we use remain very 
much the same. As we move into the future of the digital age and artificial intelligence, the 
challenge is should we continue doing the same or do we need to change and reinvent the 
discipline and the service we provide. To remain relevant, we have to embrace the change and 
move with the times. The digitization of pathology laboratories makes the specialty more 
efficient, specimen more reproducible and the work of pathologists less cumbersome. New 
technologies that produce biomedical "big data" (next generation sequenCing, multipara meter / 
multiplex flow cytometry, high"throughput proteomics and metabolomics, systems biology 
analysis) have also caused us to rethink the best approach to diagnostics. While these 
opportunities and challenges seem daunting, we still have to grapple with old challenges of 
funding and leadership. 
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